Immune infiltration, aggressive pathology, and poor survival outcomes in RECQL helicase deficient breast cancers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune infiltration, aggressive pathology, and poor survival outcomes in RECQL helicase deficient breast cancers

Published:2024-01 Issue: Volume:47 Page:100957
ISSN:1476-5586
Container-title:Neoplasia
language:en
Short-container-title:Neoplasia

Author:

Lashen Ayat,Al-Kawaz Abdulbaqi,Jeyapalan Jennie N^ORCID,Alqahtani Shatha,Shoqafi Ahmed,Algethami Mashael,Toss Michael,Green Andrew R,Mongan Nigel P^ORCID,Sharma Sudha,Akbari Mohammad R,Rakha Emad A^ORCID,Madhusudan Srinivasan^ORCID

Publisher

Elsevier BV

Subject

Cancer Research

Reference36 articles.

1. DNA helicases and their roles in cancer;Dhar;DNA Repair,2020

2. RECQ1 helicase in genomic stability and cancer;Debnath;Genes,2020

3. Unique and important consequences of RECQ1 deficiency in mammalian cells;Sharma;Cell Cycle,2008

4. RECQ1 plays a distinct role in cellular response to oxidative DNA damage;Sharma;DNA Repair,2012

5. Germline RECQL mutations are associated with breast cancer susceptibility;Cybulski;Nat. Genet.,2015

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Germline variant profiling of CHEK2 sequencing variants in breast cancer patients;Cancer Genetics;2024-11

2. Prognostic and Clinical Significance of the Proliferation Marker MCM7 in Breast Cancer;Pathobiology;2024-08-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP